Pharmacological class of CJC 1295
CJC 1295 is in the class of growth hormone releasing hormone (GHRH) mimetics. GHRH is also the name of the naturally-occurring hormone in the body, but the natural compound is not used in bodybuilding or as a performance-enhancing drug due to its high cost of manufacture and its extremely brief duration of action.. CJC 1295 is a modified version of the first 29 amino acids of GHRH, together with addition of a “Drug Affinity Complex” or DAC. The combination of modifications provides a half life of about 1 week, and steady blood levels after injection.
CJC 1295 amplifies GH production in the same way that GHRH does. Administration does not initiate a pulse of GH release. Because CJC 1295 provides steady blood levels, it increases the amplitude of natural GH pulses on an ongoing basis. It does not combine especially efficiently with a GHRP, because the DAC modification results in relatively lower ongoing levels of free peptide.
When Can I Expect To See Results?
While patients will notice some significant increases in changes in the body after the first month, the full-benefits are usually fully noticed after three to six months of therapy.
Month 1
Increased energy
Improved stamina
Deeper, more restful sleep
Month 2
Improved skin, reduced wrinkles
Stronger nails and hair
Increased metabolism
Month 3
Enhanced sex drive and performance
Improved mental focus
Improved joint health
Month 4
Continued weight reduction
Improved skin elasticity
Increased lean muscle mass
Month 5
Noticeably fuller and healthier hair
Reduced appearance of wrinkles, better skin tone
Continued reduction in belly fat
Month 6
5-10% reduction in body fat (without exercise/diet)
10% increase in lean muscle mass
Improved vitality due to organ regrowth
What Are The Benefits of CJC 1295?
CJC 1295 allows the anterior pituitary to follow the natural, pulsatile release of growth hormone without an increase in appetite stimulation, cortisol, acetylcholine, prolactin, and aldosterone. Typically, you will see CJC compounded with Ipamorelin due to its ability to stimulate GHRH for enhanced results.
Increased GH secretion and IFG-1 levels
Increased muscle growth
Increased bone density
Improved cognitive function and memory
Increased cellular repair and regeneration
Increased fat loss
Taken before bed to maximize the natural cycle of growth hormone
₹2,200
₹1,800
Careful, this Growth-Hormone-Releasing-Peptide will make you HUNGRY! If you don’t want this, stick with a different GHRP (GHRP-2, hexarelin, or ipamorelin).
For optimum results, stack this with a GHRH product (MOD GRF 1-29 or CJC 1295).
₹1,899
Hexamorelin (INN) (developmental code names EP-23905, MF-6003), also known as hexarelin, is a potent, synthetic, peptidic, orally-active, centrally-penetrant, and highly selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) and a growth hormone secretagogue which was developed by Mediolanum Farmaceutici. It is a hexapeptide with the amino acid sequence His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 which was derived from GHRP-6. These GH-releasing peptides have no sequence similarity to ghrelin, but mimic ghrelin by acting as agonists at the ghrelin receptor.
Examorelin substantially and dose-dependently increases plasma levels of growth hormone (GH) in animals and humans. In addition, similarly to pralmorelin (GHRP-2) and GHRP-6, it slightly and dose-dependently stimulates the release of prolactin, adrenocorticotropic hormone (ACTH), and cortisol in humans. There are conflicting reports on the ability of examorelin to elevate insulin-like growth factor 1 (IGF-1) and insulin-like growth factor-binding protein 1 (IGFBP-1) levels in humans, with some studies finding no increase and others finding a slight yet statistically significant increase. Examorelin does not affect plasma levels of glucose, luteinizing hormone (LH), follicle-stimulating hormone (FSH), or thyroid-stimulating hormone (TSH) in humans.
Examorelin releases more GH than does growth hormone-releasing hormone (GHRH) in humans, and produces synergistic effects on GH release in combination with GHRH, resulting in “massive” increases in plasma GH levels even with only low doses of examorelin. Pre-administration of GH blunts the GH-releasing effect of examorelin, while, in contrast, fully abolishing the effect of GHRH. Pre-treatment with IGF-1 also blunts the GH-elevating effect of examorelin.[17] Testosterone, testosterone enanthate, and ethinylestradiol, though not oxandrolone, have been found to significantly potentiate the GH-releasing effects of examorelin in humans. In accordance, likely due to increases in sex steroid levels, puberty has also been found to significantly augment the GH-elevating actions of examorelin in humans.
₹3,999
₹2,299
Ibutamoren (developmental code names MK 677, MK 0677, L-163,191; former tentative brand name Oratrope) is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin. It has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces sustained increases in the plasma levels of these hormones without affecting cortisol levels.
₹4,298
Ipamorelin is a 3rd generation GHRP behind GHRP-6 and GHRP-2. Ipamorelin has very similar characteristics of GHRP-2: does not have ghrelin’s lipogenic properties and does not promote hunger. Ipamorelin acts synergistically when applied during a Growth Hormone Releasing Hormone (GHRH) pulse or when it is administered along with a GHRH or an analog such as Sermorelin or Modified GRF 1-29 (growth releasing factor, aminos 1-29). The synergy comes both due to the suppression of somatostatin and the fact that ipamorelin increases GH release per-somatotrope, while GHRH increases the number of somatotropes releasing GH. On the other hand, Ipamorelin is similar to GHRP-6 because they both release GH at a very similar strength minus the side effects that of GHRP-6. Both GHRP-6 and GHRP-2 cause a release and an increase in cortisol and prolactin levels, however Ipamorelin only selectively releases GH at any dose. Ipamorelin shares similar functionality to Hexarelin and compared to other peptides, it is a much more stable form of ghrelin and has longer half-life periods of at least two hours long and causes secondary effect by making neurons to become excited.
Because of the way in which Ipamorelin works to stimulate the secretions relating to growth and repair, scientific study based on animal test subjects has derived a host of theorized benefits in relation to the peptide. These theorized benefits include a strengthening of bone mass, an improvement in skin tone, a boost in the burning of adipose tissue, a strengthening of connective tissue, and a strengthening and rejuvenation of joints. Due to the nature of these theorized benefits, some scientific studies have been able to determine that the peptide could play a vital role in the overall slowing down of the aging process.
₹3,299
The information on this website has not been evaluated by the US Food and Drug Administration. Our statements and products are not intended to diagnose, treat, cure, or prevent any disease.
All products on this website are sold for research, laboratory, or analytical use ONLY — they are not meant for human consumption.
By clicking "I Agree", you confirm that you are 18 years or older and you accept our Terms & Conditions.